Bruce Wendel
Director/Board Member chez GT BIOPHARMA, INC.
Fortune : 52 075 $ au 31/03/2024
Profil
Bruce Jeffrey Wendel is currently the Vice Chairman at GT Biopharma, Inc. and the Vice Chairman & EVP-Global Corporate Operations at Abraxis Health, Inc. He is also the Director at Liminal BioSciences Ltd.
and the Chief Strategy Officer at H3 Life Science Corp.
In the past, Wendel held positions such as Vice Chairman & Chief Executive Officer at Abraxis BioScience, Inc. from 2010 to 2011, Chief Executive Officer at Scientific Protein Laboratories LLC from 2014 to 2015, and Chief Executive Officer at Abraxis BioScience LLC.
He also served as an Independent Director at Verastem, Inc. from 2016 to 2021.
Wendel's former roles include VP-Corporate Development International Medicines at Bristol Myers Squibb Co. from 1988 to 2002, Vice President-Business Development & Licensing at IVAX LLC, Vice President-Corporate Development at American Pharmaceutical Partners, Inc. from 2004 to 2008, and Chief Business Development Officer at Liminal BioSciences, Inc. from 2008 to 2019.
He was also the President, Chief Financial Officer & Secretary at Stalar 3, Inc. from 2009 to 2010 and at Stalar 4, Inc. from 2009 to 2011.
Additionally, Wendel held the position of Vice President-Development at Abraxis BioScience, Inc. in 2007 and Chief Business Development Officer at ProMetic BioTherapeutics, Inc. from 2018 to 2019.
He served as the Chief Strategy Officer at Hepalink USA, Inc. from 2012 to 2017.
Wendel completed his undergraduate studies at Cornell University and obtained a graduate degree from Georgetown University Law Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GT BIOPHARMA INC
0,85% | 23/10/2023 | 11 755 ( 0,85% ) | 52 075 $ | 31/03/2024 |
Postes actifs de Bruce Wendel
| Sociétés | Poste | Début |
|---|---|---|
| GT BIOPHARMA, INC. | Director/Board Member | 11/11/2020 |
| H3 Life Science Corp. | Corporate Officer/Principal | - |
Liminal BioSciences Ltd.
 Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The private company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates. | Director/Board Member | 11/05/2016 |
Abraxis Health, Inc.
 Abraxis Health, Inc. BiotechnologyHealth Technology Abraxis Health is establishing as a fully-integrated, next-generation, evidence-based, and personalized healthcare company. It plans to develop a proprietary model for the delivery of healthcare. Abraxis Health is designing and acquiring the necessary infrastructure and plans to acquire and internally develop the hardware and software modules to organize and integrate the data streams that form the foundation of an interactive database. The firm will develop, test, and validate diagnostics and drugs to target pre-selected patients based on molecular profiles that predict drug response to particular therapeutics. | Chief Operating Officer | 30/09/2009 |
Anciens postes connus de Bruce Wendel
| Sociétés | Poste | Fin |
|---|---|---|
| VERASTEM, INC. | Director/Board Member | 18/05/2021 |
| LIMINAL BIOSCIENCES INC. | Director/Board Member | 30/05/2018 |
ProMetic BioTherapeutics, Inc.
 ProMetic BioTherapeutics, Inc. BiotechnologyHealth Technology Part of KEDRION HOLDING S.P.A., ProMetic BioTherapeutics, Inc. is a private company that manufactures plasma protein fractionation products. The company is based in Rockville, MD. ProMetic BioTherapeutics was acquired by Kedrion Biopharma, Inc. on October 18, 2021. | Corporate Officer/Principal | 01/05/2019 |
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Corporate Officer/Principal | 01/07/2017 |
Scientific Protein Laboratories LLC
 Scientific Protein Laboratories LLC Pharmaceuticals: MajorHealth Technology Scientific Protein Laboratories LLC supplies pharmaceutical ingredients. It specializes in cGMP biopharmaceutical manufacturing and commercial supplies. The firm serves the pharmaceutical, veterinary, and food industries. It offers fermentation, natural product extractions, heparin derivatives, and recovery and purification. The company founded in 1976 and is headquartered in Waunakee, WI. | Chief Executive Officer | 01/06/2015 |
Formation de Bruce Wendel
| Cornell University | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GT BIOPHARMA, INC. | Health Technology |
| LIMINAL BIOSCIENCES INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Health Technology |
American Pharmaceutical Partners, Inc.
 American Pharmaceutical Partners, Inc. Pharmaceuticals: MajorHealth Technology American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL. | Health Technology |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Stalar 3, Inc.
 Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Stalar 4, Inc.
 Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Abraxis Health, Inc.
Abraxis Health, Inc. BiotechnologyHealth Technology Abraxis Health is establishing as a fully-integrated, next-generation, evidence-based, and personalized healthcare company. It plans to develop a proprietary model for the delivery of healthcare. Abraxis Health is designing and acquiring the necessary infrastructure and plans to acquire and internally develop the hardware and software modules to organize and integrate the data streams that form the foundation of an interactive database. The firm will develop, test, and validate diagnostics and drugs to target pre-selected patients based on molecular profiles that predict drug response to particular therapeutics. | Health Technology |
Scientific Protein Laboratories LLC
Scientific Protein Laboratories LLC Pharmaceuticals: MajorHealth Technology Scientific Protein Laboratories LLC supplies pharmaceutical ingredients. It specializes in cGMP biopharmaceutical manufacturing and commercial supplies. The firm serves the pharmaceutical, veterinary, and food industries. It offers fermentation, natural product extractions, heparin derivatives, and recovery and purification. The company founded in 1976 and is headquartered in Waunakee, WI. | Health Technology |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
Abraxis BioScience LLC
 Abraxis BioScience LLC Miscellaneous Commercial ServicesCommercial Services Part of Bristol Myers Squibb Co., Abraxis BioScience LLC is a private company that researches, develops, and manufactures pharmaceutical products for cancer. The company is based in Los Angeles, CA. | Commercial Services |
ProMetic BioTherapeutics, Inc.
ProMetic BioTherapeutics, Inc. BiotechnologyHealth Technology Part of KEDRION HOLDING S.P.A., ProMetic BioTherapeutics, Inc. is a private company that manufactures plasma protein fractionation products. The company is based in Rockville, MD. ProMetic BioTherapeutics was acquired by Kedrion Biopharma, Inc. on October 18, 2021. | Health Technology |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Health Technology |
| H3 Life Science Corp. | |
Liminal BioSciences Ltd.
Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The private company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates. | Health Technology |
